TYRVAYA
Live / Registered — Registered (as of 08 Mar 2022)
What this means for you
Registered since 08 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88791700
- Registration number
- 6667405
- Mark type
- Stylized text
- Filed
- 10 Feb 2020
- Published for opposition
- 09 Jun 2020
- Registered
- 08 Mar 2022
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases
Owner
- Oyster Point Pharma, Inc., Princeton, NJ, US
- Oyster Point Pharma, Inc., Princeton, NJ, US
- Oyster Point Pharma, Inc., Princeton, NJ, US
Prosecution history
- 09 Feb 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Feb 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Aug 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Nov 2021 — USE AMENDMENT FILED